Pharmacodynamic modeling for change of locomotor activity by methylphenidate in rats

Pharmaceutical Research

Volumn 14, Issue 11, 1997, Pages 1601-1606

  Aoyama, Takao ^a   Yamamoto, Koujirou ^a   Kotaki, Hajime ^a   Sawada, Yasufumi ^b   Iga, Tatsuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Emax model; Locomotor activity; Methylphenidate; Pharmacodynamic modeling; Rats

Indexed keywords

DOPAMINE; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; INTERSTITIAL FLUID; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MICRODIALYSIS; MODEL; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DOPAMINE; LOCOMOTION; MALE; METHYLPHENIDATE; MICRODIALYSIS; MODELS, CHEMICAL; RATS; RATS, WISTAR;

EID: 0031471364     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012186519946     Document Type: Article

References (20)

1. R. A. Barkley. Psychiatry 18:137-165 (1977).
2. D. D. Daly and R. E. Yoss. Staff Meeting of Mayo Clinic 31:620-626 (1956).
3. Y. Honda, Y. Hishikawa, and Y. Takahashi. Curr. Ther. Res. 25:288-298 (1979).
4. M. M. Mitler and R. Hajdukovic. Sleep 14:218-220 (1991).
5. R. E. Yoss and D. D. Daly. Neurology 9:171-173 (1956).
6. S. P. Butcher, J. Liptrot, and G. W. Aburyhnott. Neurosci. Lett. 122:245-248 (1991).
7. Y. L. Hurd and U. Ungerstedt. Eur. J. Pharmacol. 166:251-260 (1989).
8. T. Aoyama, H. Kotaki, Y. Sawada, and T. Iga. Pharm. Res. 11:407-411 (1994).
9. T. Aoyama, H. Kotaki, Y. Sawada, and T. Iga. Psychopharmacol. 127:117-122 (1996).
10. M. Hirabayashi and M. R. Alam. Pharmac. Biochem. Behav. 15:925-932 (1981).
11. T. Sharp, T. Zetterstrom, T. Ijungberg, and T. Ungerstedt. Brain Res. 401:322-330 (1987).
12. T. Aoyama, T. Sasaki, H. Kotaki, Y. Sawada, Y. Sudoh, Y. Honda, and T. Iga. Clin. Pharmacol. Ther. 55:270-276 (1994).
13. M. J. Chow, J. J. Ambre, T. I. Ruo, A. J. Atkinson, D. J. Bowsher, and M. W. Fischman. Clin. Pharmacol. Ther. 38:318-324 (1985).
14. M. M. Hammarlund, B. O. Odlind, and L. K. Paalzow. J. Pharmacol. Exp. Ther. 233:447-453 (1985).
15. H. C. Porchet, N. L. Benowitz, and L. B. Sheiner. J. Pharmacol. Exp. Ther. 244:231-244 (1988).
16. K. Yamamoto, Y. Sawada, and T. Iga. J. Pharmcokin. Biopharm. 24:327-348 (1996).
17. P. H. Anderson. Eur. J. Pharmacol. 166:493-504 (1989).
18. J. J. Bonnet, P. Protais, A. Chagaoui, and J. Costentin. Eur. J. Pharmacol. 126:211-222 (1986).
19. Y. Deguchi, T. Terasaki, S. Kawasaki, and A. Tsuji. J. Pharmacobio-Dyn. 14:483-492 (1991).
20. A. Cowan, J. W. Lewis, and I. R. Macfarlane. Br. J. Pharmac. 43:461-462 (1971).